Evidence map›Paper›PMID 37206654›Full record

ArticleWorld journal of hepatology2023

Inferior outcomes of liver transplantation for hepatocellular carcinoma during early-COVID-19 pandemic in the United States.

Inkyu S Lee, Kenji Okumura, Ryosuke Misawa, Hiroshi Sogawa, Gregory Veillette, Devon John, Thomas Diflo, Seigo Nishida, Abhay Dhand

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of hepatology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. COVID-19 and the Liver: A Complex and Evolving Picture.Hepatic medicine : evidence and research · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Inkyu S LeeDepartment of Surgery, Westchester Medical Center, Valhalla, NY 10595, United States.
Kenji OkumuraDepartment of Surgery, Westchester Medical Center, Valhalla, NY 10595, United States. kenji.okumura@wmchealth.org.
Ryosuke MisawaDepartment of Surgery, Westchester Medical Center, Valhalla, NY 10595, United States.
Hiroshi SogawaDepartment of Surgery, Westchester Medical Center, Valhalla, NY 10595, United States.
Gregory VeilletteDepartment of Surgery, Westchester Medical Center, Valhalla, NY 10595, United States.
Devon JohnDepartment of Surgery, Westchester Medical Center, Valhalla, NY 10595, United States.
Thomas DifloDepartment of Surgery, Westchester Medical Center, Valhalla, NY 10595, United States.
Seigo NishidaDepartment of Surgery, Westchester Medical Center, Valhalla, NY 10595, United States.
Abhay DhandDepartment of Surgery, Westchester Medical Center, Valhalla, NY 10595, United States.
Westchester Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEarly in the coronavirus disease 2019 (COVID-19) pandemic, there was a significant impact on routine medical care in the United States, including in fields of transplantation and oncology.

aimTo analyze the impact and outcomes of early COVID-19 pandemic on liver transplantation (LT) for hepatocellular carcinoma (HCC) in the United States.

methodsWHO declared COVID-19 as a pandemic on March 11, 2020. We retrospectively analyzed data from the United Network for Organ Sharing (UNOS) database regarding adult LT with confirmed HCC on explant in 2019 and 2020. We defined pre-COVID period from March 11 to September 11, 2019, and early-COVID period as from March 11 to September 11, 2020.

resultsOverall, 23.5% fewer LT for HCC were performed during the COVID period (518

conclusionDuring COVID period, there was a significant decrease in LTs performed for HCC. While early postoperative outcomes of LT for HCC were same, the overall and graft survival of LTs for HCC after 180 days were significantly inferior.

Indexed as

COVID-19Graft failureHepatocellular carcinomaLiver transplantationMortalityUnited Network for Organ Sharing database

Identifiers

PMID37206654
PMCPMC10190691
OpenAlexW4366541767

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.